These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24468312)

  • 41. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
    Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scimè R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P
    Leukemia; 2012 Mar; 26(3):520-6. PubMed ID: 21904377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and pathological diagnosis of peripheral T-cell lymphoma and emerging treatment options: A case-based discussion.
    Said J; Pinter-Brown L
    Clin Adv Hematol Oncol; 2009 Nov; 7(11):S1, S4-13; quiz S15. PubMed ID: 20095101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The potential of pralatrexate as a treatment of peripheral T-cell lymphoma.
    Dondi A; Bari A; Pozzi S; Ferri P; Sacchi S
    Expert Opin Investig Drugs; 2014 May; 23(5):711-8. PubMed ID: 24661228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.
    Blystad AK; Enblad G; Kvaløy S; Berglund A; Delabie J; Holte H; Carlson K; Kvalheim G; Bengtsson M; Hagberg H
    Bone Marrow Transplant; 2001 Apr; 27(7):711-6. PubMed ID: 11360110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of new agents for peripheral T-cell lymphoma.
    Ito Y; Makita S; Tobinai K
    Expert Opin Biol Ther; 2019 Mar; 19(3):197-209. PubMed ID: 30658046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation.
    Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M
    Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival benefit in patients with peripheral T-cell lymphomas after treatments with novel therapies and clinical trials.
    Ma H; Cheng B; Falchi L; Marchi E; Sawas A; Bhagat G; O'Connor OA
    Hematol Oncol; 2020 Feb; 38(1):51-58. PubMed ID: 31872891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes.
    Allen PB; Pro B
    Curr Oncol Rep; 2020 Apr; 22(5):44. PubMed ID: 32297075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The changing landscape of peripheral T-cell lymphoma in the era of novel therapies.
    Karlin L; Coiffier B
    Semin Hematol; 2014 Jan; 51(1):25-34. PubMed ID: 24468313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transplantation.
    Zain J
    Cancer Treat Res; 2019; 176():269-287. PubMed ID: 30596223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease.
    Broccoli A; Argnani L; Zinzani PL
    Cancer Treat Rev; 2017 Nov; 60():120-129. PubMed ID: 28946015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.
    Han X; Zhang W; Zhou D; Ruan J; Duan M; Zhu T; Li J; Cai H; Cao X; Ouyang M
    J Int Med Res; 2017 Feb; 45(1):290-302. PubMed ID: 28222648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.
    Hapgood G; Latimer M; Lee ST; Kuss B; Lade S; Tobin JWD; Purtill D; Campbell BA; Prince HM; Hawkes EA; Shortt J; Radeski D
    Intern Med J; 2022 Oct; 52(10):1806-1817. PubMed ID: 34668281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral T-cell lymphoma: a case-based discussion of recent advances in patient management.
    Franco CM; Popplewell LL; Horwitz SM
    Clin Adv Hematol Oncol; 2011 Apr; 9(4 Suppl 9):1-16. PubMed ID: 21559001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Practical Treatment Approach for Angioimmunoblastic T-Cell Lymphoma.
    Moskowitz AJ
    J Oncol Pract; 2019 Mar; 15(3):137-143. PubMed ID: 30861367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
    Perrone G; Farina L; Corradini P
    Expert Rev Hematol; 2013 Aug; 6(4):465-74. PubMed ID: 23991932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
    O'Connor OA; Bhagat G; Ganapathi K; Pedersen MB; D'Amore F; Radeski D; Bates SE
    Clin Cancer Res; 2014 Oct; 20(20):5240-54. PubMed ID: 25320373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
    Ahn JS; Yang DH; Jung SH; Chae YS; Sohn SK; Yhim HY; Kwak JY; Lee SR; Kim YK; Kim HJ; Lee JJ
    Ann Hematol; 2013 Jun; 92(6):789-97. PubMed ID: 23358616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
    Puig N; Wang L; Seshadri T; al-Farsi K; Keating A; Crump M; Kuruvilla J
    Leuk Lymphoma; 2013 Mar; 54(3):507-13. PubMed ID: 22897731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.